Biomarker-Guided Strategy for Treatment of Autism Spectrum Disorder (ASD)

E-ISSN： 1996-3181|15|5|602-613

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.15, Iss.5, 2016-05, pp. : 602-613

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sulforaphane Treatment of Young Men with Autism Spectrum Disorder

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 5, 2016-05 ,pp. : 597-601

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolic Side Effects of Antipsychotic Medications in Children and Adolescents with Autism Spectrum Disorder (ASD)

Child and Adolescent Psychopharmacology News, Vol. 21, Iss. 3, 2016-06 ,pp. : 1-9

Guilford Publications Inc

Access to resources Recommend Favorite

Non-Pharmacological Treatment of Problem Behaviors in Children with Autism Spectrum Disorder

Child and Adolescent Psychopharmacology News, Vol. 16, Iss. 3, 2011-06 ,pp. : 9-11

Guilford Publications Inc

Access to resources Recommend Favorite

Copy-number variations associated with autism spectrum disorder

By Kakinuma Hiroaki Sato Hitoshi

Pharmacogenomics, Vol. 9, Iss. 8, 2008-08 ,pp. : 1143-1154

Future Medicine

Access to resources Recommend Favorite

Cannabidiol as a Putative Novel Therapy for Diabetic Retinopathy: A Postulated Mechanism of Action as an Entry Point for Biomarker-Guided Clinical Development

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 7, Iss. 3, 2009-01 ,pp. : 215-222

Bentham Science Publishers

Access to resources Recommend Favorite